NIH Honors Emory Researcher With Merit Award For Work On Renin-Angiotensin System

October 23, 1997

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has granted Kenneth Bernstein, MD, professor of Pathology and Laboratory Medicine, a MERIT award in recognition of his "consistent and excellent contributions to scientific knowledge." MERIT (Method to Extend Research in Time) awards extend the normal time period for a research grant, providing a few outstanding investigators with the opportunity for long-term stable support that will enhance their continued scientific creativity and lessen the administrative burdens of preparing and submitting grant applications.

The $2-million MERIT award is an eight-year grant extending Dr. Bernstein?s original NIH grant awarded in 1988 when he first joined the Emory faculty. He also is an investigator under Emory's O'Brien Kidney Center NIH grant and principal investigator for three other NIH R01 grants.

During the past 10 years Bernstein and his colleagues have been responsible for a number of key scientific discoveries that have transformed the way in which scientists view the renin-angiotensin system and its effects on cardiovascular function. In 1989 they became one of the first laboratories in the world to isolate and clone the gene for the angiotensin converting enzyme (ACE), which controls the production of angiotensin II-the link between the kidneys and blood pressure control (Journal of Biological Chemistry, 1989).

When blood pressure drops, the kidney attempts to counterbalance the drop by releasing the enzyme, renin. Renin in turn catalyzes the production of angiotensin, a hormone circulating in the blood. The ACE enzyme converts the inactive form of angiotensin-'antiotensin I' to angiotensin II, which is a powerful vasopressor (constricter of blood vessels).

Through its vasopressor action, angiotensin II raises blood pressure and, through a variety of physiologic effects, decreases fluid loss by the kidney. For example, angiotensin II stimulates the adrenal cortex to secret aldosterone, which regulates the body's electrolyte and water balance by promoting the retention of sodium (and therefore of water) and the excretion of potassium. The retention of water induces an increase in plasma volume and thus an increase in blood pressure.

To further elucidate the effects of angiotensin, Bernstein, using a rodent model, isolated and cloned the gene encoding the receptor for angiotensin II (Nature 1991), which has become known as the AT1 receptor. This receptor has since been demonstrated to be responsible for virtually all of the physiologic and cardiovascular effects of angiotensin II. The importance of the AT1 receptor in basic science research is evident from the more than 1,000 scientific articles that have been published since 1993 detailing its biology.

"Everybody would accept the fact that while blood pressure is very complex and multifactorial," says Bernstein, "in the middle is angiotensin II with its many effects on smooth muscle, the heart, the kidney, the adrenal, the brain and the gut, all of which act coordinately to maintain blood pressure. By understanding and cloning this receptor, we have given people an immense, powerful tool to study the regulation of blood pressure and to understand this multisystem process that maintains our blood."

In a 1994 article in Nature, Bernstein described the unique messaging pathway used by the AT1 receptor to send messages from the cell surface to the cell nucleus. In response to angiotensin II, the AT1 receptor activates an intracellular messenger called the Jak2 kinase, which in turn initiates a cascade of signals often referred to as the Jak-STAT pathway. Through this cascading pathway, messages are sent from the cell surface to the cell nucleus. Although receptors for several other kinds of cell mediators are known to use this pathway, the AT1 receptor is a member of the class of receptors called "seven transmembrane receptors," or "G-protein associated receptors."

Whereas scientists previously believed these receptors used a different type of signaling, Bernstein's work was the first observation that any of the seven transmembrane receptors was capable of activating the Jak-STAT pathway. Because the seven transmembrane receptors are a superfamily of hundreds of receptors, discovery of this unique messaging system has given researchers insight into previously unknown signaling pathways for the entire class of receptors, which include those for a variety of critical bodily functions.

ACE in Reproductive Biology

One of the most interesting aspects of ACE biology is the two different manifestations, or isozymes, of the enzyme. The terms for these two different isozymes-somatic ACE and testis ACE-were first coined by Bernstein's group. Somatic ACE , found in the lungs, the kidneys, and in blood vessels throughout the body, is the form commonly associated with control of blood pressure, but the other form-testis ACE-is made exclusively by developing male sperm cells. Bernstein's study of testis ACE has focused on two critical dilemmas: (1) How is this unique form of ACE made in such a restricted, tissue-specific fashion? and (2) Is there any real physiological role of testis ACE in male reproductive biology? He answered the first question through his discovery that the transcription of testis ACE in the mouse is initiated by a testis-specific promoter located within a certain portion of the somatic ACE gene-a finding later confirmed in the human gene. To determine whether testis ACE has any real importance in male reproduction, Bernstein created recombinant knockout mice containing no somatic or testis ACE gene. He found that the male knockout mice fathered litters with much smaller numbers of offspring than those of typical wild mice, suggesting that testis ACE is necessary for full male fertility (Laboratory Investigation, 1994). In addition, mice lacking somatic ACE have an unusual renal phenotype characterized by the inability to effectively concentrate urine.

"These are very fundamental questions that go to the very basis of what makes one cell different from another cell," says Bernstein. "By understanding the function of testis ACE, we get a real insight into the basic makeup of what we are, which is a creature of many different tissues, each of which is responsible for a functionality."

Bernstein's current research focuses on three areas: the intracellular signals initiated when angiotensin II binds to the AT1 receptor; creating new knockout mice to understand more about the physiologic role of ACE in reproduction and blood pressure; and the biochemistry of testis ACE expression as a model of tissue-specific gene expression.

Emory University Health Sciences Center

Related Blood Pressure Articles from Brightsurf:

Children who take steroids at increased risk for diabetes, high blood pressure, blood clots
Children who take oral steroids to treat asthma or autoimmune diseases have an increased risk of diabetes, high blood pressure, and blood clots, according to Rutgers researchers.

High blood pressure treatment linked to less risk for drop in blood pressure upon standing
Treatment to lower blood pressure did not increase and may decrease the risk of extreme drops in blood pressure upon standing from a sitting position.

Changes in blood pressure control over 2 decades among US adults with high blood pressure
National survey data were used to examine how blood pressure control changed overall among U.S. adults with high blood pressure between 1999-2000 and 2017-2018 and by age, race, insurance type and access to health care.

Transient increase in blood pressure promotes some blood vessel growth
Blood vessels are the body's transportation system, carrying oxygen and nutrients to cells and whisking away waste.

Effect of reducing blood pressure medications on blood pressure control in older adults
Whether the amount of blood pressure medications taken by older adults could be reduced safely and without a significant change in short-term blood pressure control was the objective of this randomized clinical trial that included 534 adults 80 and older.

Brain blood flow sensor discovery could aid treatments for high blood pressure & dementia
A study led by researchers at UCL has discovered the mechanism that allows the brain to monitor its own blood supply, a finding in rats which may help to find new treatments for human conditions including hypertension (high blood pressure) and dementia.

Here's something that will raise your blood pressure
The apelin receptor (APJ) has been presumed to play an important role in the contraction of blood vessels involved in blood pressure regulation.

New strategy for treating high blood pressure
The key to treating blood pressure might lie in people who are 'resistant' to developing high blood pressure even when they eat high salt diets, shows new research published today in Experimental Physiology.

Arm cuff blood pressure measurements may fall short for predicting heart disease risk in some people with resistant high blood pressure
A measurement of central blood pressure in people with difficult-to-treat high blood pressure could help reduce risk of heart disease better than traditional arm cuff readings for some patients, according to preliminary research presented at the American Heart Association's Hypertension 2019 Scientific Sessions.

Heating pads may lower blood pressure in people with high blood pressure when lying down
In people with supine hypertension due to autonomic failure, a condition that increases blood pressure when lying down, overnight heat therapy significantly decreased systolic blood pressure compared to a placebo.

Read More: Blood Pressure News and Blood Pressure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to